Enzo Biochem Inc. (ENZ)
0.35
0.03 (8.02%)
At close: Apr 14, 2025, 3:59 PM
0.34
-1.97%
After-hours: Apr 14, 2025, 08:00 PM EDT
8.02% (1D)
| Bid | 0.34 |
| Market Cap | 18.21M |
| Revenue (ttm) | 29.09M |
| Net Income (ttm) | -21.31M |
| EPS (ttm) | -0.14 |
| PE Ratio (ttm) | -2.48 |
| Forward PE | -1.63 |
| Analyst | n/a |
| Ask | 0.35 |
| Volume | 255,981 |
| Avg. Volume (20D) | 212,639 |
| Open | 0.31 |
| Previous Close | 0.32 |
| Day's Range | 0.30 - 0.35 |
| 52-Week Range | 0.25 - 1.27 |
| Beta | 1.16 |
About ENZ
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products segment develops, manufactures, and markets products and tools to clinical res...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 12, 1980
Employees 125
Stock Exchange NYSE
Ticker Symbol ENZ
Website https://www.enzo.com
4 weeks ago
+5.62%
Enzo Biochem shares are trading higher after the c...
Unlock content with
Pro Subscription
3 months ago
-30.69%
Enzo Biochem shares are trading lower after the company reported a year-over-year decrease in Q1 revenue results.
